Evotec has entered an exclusive strategic collaboration with the Fraunhofer Institute for internal and external drug discovery projects in several disease areas using a combination platforms from both organizations. The alliance expands Evotec’s drug discovery platform with access to a range of platforms and capabilities to use on its own projects and for customers and partners.   Dr. Werner Lanthaler, chief executive officer of Evotec, said, “We are looking forward to partner with F...